Publications by authors named "Kathy Pearson"

Claim this Profile
V
Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.
Andrew G Glass, Michael C Leo, Zaid Haddad, Kasra Yousefi, Marguerite du Plessis, Kathy Pearson

J Urol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient Safety Leadership Academy at the University of Pennsylvania: the first cohort's learning experience.
Angela B Wurster, Kathy Pearson, Seema S Sonnad, James L Mullen, Larry R Kaiser

Qual Manag Health Care· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
Lisa M Broad, Ruud Zwart, Kathy H Pearson, Martin Lee, Louise Wallace

J Pharmacol Exp Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy executive leadership issues and associated skills, knowledge, and abilities.
Andrew B Meadows, Lucinda L Maine, Elizabeth K Keyes, Kathy Pearson, Kenn Finstuen

J Am Pharm Assoc (2003)· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening.
Peter J Craig, Suchira Bose, Ruud Zwart, Ruth E Beattie, Elizabeth A Folly, Kathy H Pearson

Eur J Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties.
Non M Evans, Suchira Bose, Giovanni Benedetti, Ruud Zwart, Kathy H Pearson

Eur J Pharmacol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor.
Lisa M Broad, Catherine Felthouse, Ruud Zwart, Gordon I McPhie, Kathy H Pearson

Eur J Pharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis